Post pandemic anxiety disorder treatment market has surged by 28.2%

New Delhi: The global generalized anxiety disorder treatment market is expected to garner a market value of US$ 1800 Million in 2023 and is expected to accumulate a market value of US$ 4261.25 Million by registering a CAGR of 9% in the forecast period 2023 to 2033.

Growth of the generalized anxiety disorder treatment market can be attributed to increasing prevalence of mental health disorders along with availability of numerous treatments to treat the ailment. The market for generalized anxiety disorder treatment registered a CAGR of 5.1% in the historical period 2018 to 2022.

Generalized anxiety disorder is a mental health disorder characterized by excessive and persistent worry or anxiety about various events or activities, even when there is little or no reason to worry. Generalized anxiety disorder can be a chronic condition and can significantly affect a person’s daily life. There are several treatment options for generalized anxiety disorder that includes Cognitive-behavioral therapy (CBT), Medications, relaxation techniques, lifestyle changes and support groups.

Prominent Drivers of Generalized Anxiety Disorder Treatment Market?

Growing prevalence and awareness regarding mental health accelerating market growth of generalized anxiety disorder

The prevalence of generalized anxiety disorder is increasing worldwide, which is expected to drive the demand for generalized anxiety disorder treatment. According to the World Health Organization (WHO), anxiety disorders affect approximately 3.6% of the global population.

There is a growing awareness about mental health issues, including generalized anxiety disorder, which is driving the demand for generalized anxiety disorder treatment. This is expected to further boost the generalized anxiety disorder treatment market.

There have been significant advances in the treatment options available for generalized anxiety disorder, including new medications and therapies, which are expected to drive the growth of the generalized anxiety disorder treatment market.

The increasing healthcare spending and government initiatives to improve mental health services are also expected to drive the growth of the generalized anxiety disorder treatment market.

Availability of therapies and treatments increasing the dependency on generalized anxiety disorder treatment

Cognitive-behavioral therapy (CBT): CBT is a type of talk therapy that focuses on changing negative thought patterns and behaviors. It can be an effective treatment for GENERALIZED ANXIETY DISORDER and can help a person learn to manage their anxiety.

Medications: Antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), are commonly used to treat generalized anxiety disorder. These medications can help regulate brain chemicals that contribute to anxiety.

Relaxation techniques: Relaxation techniques, such as deep breathing, meditation, and progressive muscle relaxation, can help a person manage their anxiety symptoms.

Lifestyle changes: Regular exercise, a healthy diet, and getting enough sleep can all help manage anxiety symptoms.

Support groups: Support groups can provide a supportive and understanding community for people with generalized anxiety disorder.

Challenges Faced by the Generalized Anxiety Disorder Treatment Market?

Limited access to mental health services affecting overall market growth

Stigma associated with mental health issues, including generalized anxiety disorder, can be a significant barrier to seeking and receiving treatment. This can limit the growth of the generalized anxiety disorder treatment market. The cost of generalized anxiety disorder treatment, including medications and therapy, can be high, which can limit access to treatment for those who cannot afford it. This is a significant challenge, particularly in developing countries.

There is a shortage of mental health professionals, particularly in rural areas, which can limit access to treatment for those in need. A lack of awareness about generalized anxiety disorder and the available treatment options can also be a challenge. Many people may not be aware that they have generalized anxiety disorder or may not know where to seek help.

The side effects of medications used to treat generalized anxiety disorder can be significant, and some people may not tolerate them well, which can limit the effectiveness of the treatment.

Generalized anxiety disorder is often comorbid with other mental health disorders, such as depression, which can complicate treatment and make it more challenging to manage. All these factors are affecting the growth of the generalized anxiety disorder treatment market.

Region-Wise Insights

Demand for Alternative Therapies Increasing Demand for Generalized Anxiety Disorder Treatment Market?

Presence of key players boosting implementation of generalized anxiety disorder treatment

The North America generalized anxiety disorder treatment market is expected to grow significantly in the coming years due to the increasing prevalence of generalized anxiety disorder and the growing awareness of the condition. Some of the major players in the market include pharmaceutical companies such as Pfizer Inc., Eli Lilly and Company, and GlaxoSmithKline plc, which develop and market medications used to manage symptoms of generalized anxiety disorder.

The North America generalized anxiety disorder treatment market is also impacted by the increasing demand for alternative therapies and natural remedies. As such, there has been an increase in the use of herbal supplements, mindfulness meditation, and yoga to manage symptoms of generalized anxiety disorder.

Market Competition

MindMed, a key player in the generalized anxiety disorder treatment market has explored the potential therapeutic benefits of 5-MeO-DMT, a naturally occurring psychedelic substance that is found in various plants and animals. In preclinical studies, MindMed has found that 5-MeO-DMT may have anxiolytic (anti-anxiety) effects, potentially making it a useful treatment option for individuals with generalized anxiety disorder.

Actavis, a key player in the generalized anxiety disorder treatment market is offering a number of drugs that are used in the treatment of anxiety disorders, such as the antidepressant escitalopram, which is sold under the brand name Lexapro.

These insights are based on a report Generalized Anxiety Disorder Treatment Market by Future Market Insights.